These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 20131231

  • 21. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR, Simpson DF, Hurley BL, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [Abstract] [Full Text] [Related]

  • 22. Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus.
    Reichlin M, Fesmire J, Quintero-Del-Rio AI, Wolfson-Reichlin M.
    Arthritis Rheum; 2002 Nov; 46(11):2957-63. PubMed ID: 12428237
    [Abstract] [Full Text] [Related]

  • 23. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC.
    Arthritis Res Ther; 2006 Nov; 8(6):R162. PubMed ID: 17062137
    [Abstract] [Full Text] [Related]

  • 24. Studies of serum C-reactive protein in systemic lupus erythematosus.
    Williams RC, Harmon ME, Burlingame R, Du Clos TW.
    J Rheumatol; 2005 Mar; 32(3):454-61. PubMed ID: 15742436
    [Abstract] [Full Text] [Related]

  • 25. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Petri MA, van Vollenhoven RF, Buyon J, Levy RA, Navarra SV, Cervera R, Zhong ZJ, Freimuth WW, BLISS-52 and BLISS-76 Study Groups.
    Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628
    [Abstract] [Full Text] [Related]

  • 26. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.
    Guo H, Leung JC, Chan LY, Chan TM, Lai KN.
    Rheumatology (Oxford); 2004 Mar; 43(3):286-93. PubMed ID: 14623950
    [Abstract] [Full Text] [Related]

  • 27. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations.
    Stohl W, Metyas S, Tan SM, Cheema GS, Oamar B, Xu D, Roschke V, Wu Y, Baker KP, Hilbert DM.
    Arthritis Rheum; 2003 Dec; 48(12):3475-86. PubMed ID: 14673998
    [Abstract] [Full Text] [Related]

  • 28. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
    Sjöwall C, Olin AI, Skogh T, Wetterö J, Mörgelin M, Nived O, Sturfelt G, Bengtsson AA.
    Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
    [Abstract] [Full Text] [Related]

  • 29. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Feng X, Wu H, Grossman JM, Hanvivadhanakul P, FitzGerald JD, Park GS, Dong X, Chen W, Kim MH, Weng HH, Furst DE, Gorn A, McMahon M, Taylor M, Brahn E, Hahn BH, Tsao BP.
    Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
    [Abstract] [Full Text] [Related]

  • 30. Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus.
    Shoenfeld Y, Szyper-Kravitz M, Witte T, Doria A, Tsutsumi A, Tatsuya A, Dayer JM, Roux-Lombard P, Fontao L, Kallenberg CG, Bijl M, Matthias T, Fraser A, Zandman-Goddard G, Blank M, Gilburd B, Meroni PL.
    Ann N Y Acad Sci; 2007 Jun; 1108():227-39. PubMed ID: 17899624
    [Abstract] [Full Text] [Related]

  • 31. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease.
    Reichlin M, Broyles TF, Hubscher O, James J, Lehman TA, Palermo R, Stafford HA, Taylor-Albert E, Wolfson-Reichlin M.
    Arthritis Rheum; 1999 Jan; 42(1):69-75. PubMed ID: 9920016
    [Abstract] [Full Text] [Related]

  • 32. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
    Morgan PE, Sturgess AD, Davies MJ.
    Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
    [Abstract] [Full Text] [Related]

  • 33. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
    Sarzi-Puttini P, Atzeni F, Carrabba M.
    Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
    [Abstract] [Full Text] [Related]

  • 34. Raised serum APRIL levels in patients with systemic lupus erythematosus.
    Koyama T, Tsukamoto H, Miyagi Y, Himeji D, Otsuka J, Miyagawa H, Harada M, Horiuchi T.
    Ann Rheum Dis; 2005 Jul; 64(7):1065-7. PubMed ID: 15576416
    [Abstract] [Full Text] [Related]

  • 35. Elevated serum anti-endothelial cell autoantibodies titer is associated with lupus nephritis in patients with systemic lupus erythematosus.
    Tseng JC, Lu LY, Hu RJ, Kau CK, Cheng HH, Lin PR, Sun CW, Liang HT, Lam HC, Tai MH.
    J Microbiol Immunol Infect; 2007 Feb; 40(1):50-5. PubMed ID: 17332907
    [Abstract] [Full Text] [Related]

  • 36. VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype.
    Bhat NM, Lee LM, van Vollenhoven RF, Teng NN, Bieber MM.
    J Rheumatol; 2002 Oct; 29(10):2114-21. PubMed ID: 12375320
    [Abstract] [Full Text] [Related]

  • 37. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK.
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [Abstract] [Full Text] [Related]

  • 38. Circulating anti-double-stranded DNA antibody-secreting cells in patients with systemic lupus erythematosus: a novel biomarker for disease activity.
    Hanaoka H, Okazaki Y, Satoh T, Kaneko Y, Yasuoka H, Seta N, Kuwana M.
    Lupus; 2012 Oct; 21(12):1284-93. PubMed ID: 22740429
    [Abstract] [Full Text] [Related]

  • 39. Anti-apolipoprotein A-I autoantibody: characterization of monoclonal autoantibodies from patients with systemic lupus erythematosus.
    Abe H, Tsuboi N, Suzuki S, Sakuraba H, Takanashi H, Tahara K, Tonozuka N, Hayashi T, Umeda M.
    J Rheumatol; 2001 May; 28(5):990-5. PubMed ID: 11361227
    [Abstract] [Full Text] [Related]

  • 40. Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus.
    López P, Rodríguez-Carrio J, Martínez-Zapico A, Pérez-Álvarez ÁI, López-Mejías R, Benavente L, Mozo L, Caminal-Montero L, González-Gay MA, Suárez A.
    Thromb Haemost; 2017 Nov; 117(11):2194-2206. PubMed ID: 29044294
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.